NCT00314756View on ClinicalTrials.gov

Treatment of Nodular Basal Cell Carcinoma (BCC) With Imiquimod 5% Cream After Curettage

PHASE4CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

March 31, 2005

Study Completion Date

November 30, 2005

Conditions
Basal Cell Carcinoma
Interventions
DRUG

imiquimod

Trial Locations (1)

27157

Wake Forest University Medical Center, Winston-Salem

All Listed Sponsors
lead

Wake Forest University

OTHER

NCT00314756 - Treatment of Nodular Basal Cell Carcinoma (BCC) With Imiquimod 5% Cream After Curettage | Biotech Hunter | Biotech Hunter